A Nevada jury is ordering pharmaceutical companies to pay $162.5 million in punitive damages in a lawsuit stemming from a Las Vegas hepatitis C outbreak in 2008.
The damages awarded Monday in Clark County District Court are on top of the $20.1 million in compensatory damages awarded to five plaintiffs Thursday after a jury found Teva Parenteral Medicines Inc., Baxter Healthcare Corp. and McKesson Corp. liable after a seven-week trial.
Plaintiffs’ lawyers had been seeking $600 million in punitive damages.
At least one of the drug companies is planning an immediate appeal.
Plaintiffs accused the drug companies of distributing dangerously large vials of the powerful anesthetic propofol to clinics where doctors and anesthesiologists are suspected of reusing vials – despite warnings that the practice could spread blood-borne diseases.
Was this article valuable?
Here are more articles you may enjoy.
California Bill Would Require Insurer Claims Handling Plans, And Double Penalties
Billionaire NFL Owner Suing Over Billboards Near His SoFi Stadium
Allianz Built An AI Agent to Train Claims Professionals in Virtual Reality
NYC Sues Delivery App Over Lost Pay in New Mamdani Crackdown